These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7217408)
1. Differential effects of maternal and sibling presence of hyperactivity of 6-hydroxydopamine-treated developing rats. Teicher MH; Shaywitz BA; Kootz HL; Cohen DJ J Comp Physiol Psychol; 1981 Feb; 95(1):134-45. PubMed ID: 7217408 [TBL] [Abstract][Full Text] [Related]
2. The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup. Shaywitz BA; Gordon JW; Klopper JH; Zelterman DA Pharmacol Biochem Behav; 1977 Apr; 6(4):391-6. PubMed ID: 882577 [TBL] [Abstract][Full Text] [Related]
3. Open-field behavior in dopamine-depleted rat pups and their mothers. Concannon JT; Schechter MD Pharmacol Biochem Behav; 1983 Feb; 18(2):285-7. PubMed ID: 6403951 [TBL] [Abstract][Full Text] [Related]
4. The development of brain biogenic amines, cyclic nucleotides and hyperactivity in 6-OHDA-treated rat pups. Concannon JT; Braughler JM; Schechter MD Pharmacol Biochem Behav; 1983 Apr; 18(4):477-82. PubMed ID: 6306694 [TBL] [Abstract][Full Text] [Related]
5. Effects of apomorphine on escape performance and activity in developing rat pups treated with 6-hydroxydopamine (6-OHDA). Lipton SV; McGough JP; Shaywitz BA Pharmacol Biochem Behav; 1980 Sep; 13(3):371-7. PubMed ID: 7191569 [TBL] [Abstract][Full Text] [Related]
6. Effects of bromocriptine in developing rat pups after 6-hydroxydopamine. Shaywitz BA; Lipton SV; Teicher MH; Cohen DJ; Anderson GM; Batter DK; Young JG Pharmacol Biochem Behav; 1981 Sep; 15(3):443-8. PubMed ID: 6794039 [TBL] [Abstract][Full Text] [Related]
7. Environmental and biologic interactions on behavior: effects of artificial rearing in rat pups treated with 6-hydroxydopamine. Goldenring JR; Shaywitz BA; Wool RS; Batter DK; Anderson GM; Cohen DJ Dev Psychobiol; 1982 Jul; 15(4):297-307. PubMed ID: 6809512 [No Abstract] [Full Text] [Related]
8. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Miller FE; Heffner TG; Kotake C; Seiden LS Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194 [TBL] [Abstract][Full Text] [Related]
9. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup. Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833 [TBL] [Abstract][Full Text] [Related]
10. Failure of amphetamine isomers to decrease hyperactivity in developing rats. Concannon JT; Schechter MD Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666 [TBL] [Abstract][Full Text] [Related]
12. Effects of chronic administration of food colorings on activity levels and cognitive performance in developing rat pups treated with 6-hydroxydopamine. Shaywitz BA; Goldenring JR; Wool RS Neurobehav Toxicol; 1979; 1(1):41-7. PubMed ID: 551301 [No Abstract] [Full Text] [Related]
13. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine. Heffner TG; Seiden LS Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184 [TBL] [Abstract][Full Text] [Related]
14. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine]. Iwasaki T; Takasuna M Yakubutsu Seishin Kodo; 1986 Dec; 6(4):381-8. PubMed ID: 3103348 [TBL] [Abstract][Full Text] [Related]
15. [Right/left discrimination learning in rat pups neonatally treated with 6-hydroxydopamine]. Takasuna M; Iwasaki T Yakubutsu Seishin Kodo; 1990 Jun; 10(2):315-21. PubMed ID: 2123587 [TBL] [Abstract][Full Text] [Related]
16. Effect of phenobarbital on activity and learning in 6-hydroxydopamine treated rat pups. Shaywitz BA; Pearson DA Pharmacol Biochem Behav; 1978 Aug; 9(2):173-9. PubMed ID: 714967 [No Abstract] [Full Text] [Related]
17. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction. Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333 [TBL] [Abstract][Full Text] [Related]
18. Environmental influences on body weight and behavior in developing rats after neonatal 6-hydroxydopamine. Pearson DE; Teicher MH; Shaywitz BA; Cohen DJ; Young JG; Anderson GM Science; 1980 Aug; 209(4457):715-7. PubMed ID: 7394533 [TBL] [Abstract][Full Text] [Related]
19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
20. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood. Fobes JL; Olds ME Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]